A Phase 3 Study of Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF) in Patients With HBeAg-negative, Chronic Hepatitis B (CHB): Week 48 Efficacy and Safety Results

Lik-Yuen Chan, Henry ; Fung, Scott ; Seto, Wai Kay ; Chuang, Wan-Long ; Chen, Chi-Yi ; Kim, Hyung Joon ; Hui, Aric Josun ; Janssen, Harry ; Chowdhury, Abhijit ; Owen Tsang, Tak Yin ; Mehta, Rajiv ; Gane, Edward ; Lim, Seng Gee ; Flaherty, John F. ; Massetto, Benedetta ; Kitrinos, Kathryn ; Dinh, Phillip ; Subramanian, Mani ; McHutchison, John ; Lu, Yiwei ; Lim, Young-Suk ; Acharya, Subrat ; Agarwal, Kosh (2017) A Phase 3 Study of Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF) in Patients With HBeAg-negative, Chronic Hepatitis B (CHB): Week 48 Efficacy and Safety Results Clinical Gastroenterology and Hepatology, 15 (1). e44. ISSN 15423565

Full text not available from this repository.

Official URL: http://doi.org/10.1016/j.cgh.2016.09.108

Related URL: http://dx.doi.org/10.1016/j.cgh.2016.09.108


Item Type:Article
ID Code:128848
Deposited On:22 Nov 2022 09:14
Last Modified:22 Nov 2022 09:14

Repository Staff Only: item control page